Cargando…
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
BACKGROUND: We previously reported an accurate urine-based bladder cancer (BCa)-associated diagnostic signature that can be used to non-invasively detect BCa. In this study, we investigated whether a component of this signature could risk stratify patients with BCa. METHODS: Utilizing immunohistoche...
Autores principales: | Chan, Owen T.M., Furuya, Hideki, Pagano, Ian, Shimizu, Yoshiko, Hokutan, Kanani, Dyrskjøt, Lars, Jensen, Jørgen Bjerggaard, Malmstrom, Per-Uno, Segersten, Ulrika, Janku, Filip, Rosser, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725126/ https://www.ncbi.nlm.nih.gov/pubmed/29245935 http://dx.doi.org/10.18632/oncotarget.20686 |
Ejemplares similares
-
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
por: Furuya, Hideki, et al.
Publicado: (2022) -
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation
por: Peres, Rafael, et al.
Publicado: (2016) -
Plasminogen activator inhibitor-2
(PAI-2) overexpression supports
bladder cancer development
in PAI-1 knockout mice in N-butyl-N-
(4-hydroxybutyl)-nitrosamine- induced bladder
cancer mouse model
por: Furuya, Hideki, et al.
Publicado: (2020) -
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
por: Murakami, Kaoru, et al.
Publicado: (2023) -
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)